These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 11843168)

  • 1. Unchanged global fibrinolytic capacity despite increased factor VIIa activity in Behçet's disease: evidence of a prethrombotic state.
    Ozatli D; Sayinalp N; Büyükaşik Y; Karakuş S; Haznedaroglu IC; Kirazli S; Ozcebe O; Dündar SV
    Rheumatol Int; 2002 Jan; 21(4):137-40. PubMed ID: 11843168
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Coagulation parameters and plasma total homocysteine levels in Behcet's disease.
    Lee YJ; Kang SW; Yang JI; Choi YM; Sheen D; Lee EB; Choi SW; Song YW
    Thromb Res; 2002 Apr; 106(1):19-24. PubMed ID: 12165284
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Coagulation and fibrinolytic activity in Behçet's disease.
    Hampton KK; Chamberlain MA; Menon DK; Davies JA
    Thromb Haemost; 1991 Sep; 66(3):292-4. PubMed ID: 1745999
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of coagulation parameters for healthy subjects and Behçet disease patients with and without vascular involvement.
    Sengül N; Demirer S; Yerdel MA; Terzioğlu G; Akin B; Gürler A; Tüzüner A
    World J Surg; 2000 Dec; 24(12):1584-8. PubMed ID: 11193728
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thrombin activatable fibrinolysis inhibitor in Behçet's disease.
    Donmez A; Aksu K; Celik HA; Keser G; Cagirgan S; Omay SB; Inal V; Aydin HH; Tombuloglu M; Doganavsargil E
    Thromb Res; 2005; 115(4):287-92. PubMed ID: 15668188
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Behçet's disease: new insight into the relationship between procoagulant state, endothelial activation/damage and disease activity.
    Fernández-Bello I; López-Longo FJ; Arias-Salgado EG; Jiménez-Yuste V; Butta NV
    Orphanet J Rare Dis; 2013 May; 8():81. PubMed ID: 23711081
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pathological haemostasis and "prothrombotic state" in Behçet's disease.
    Kiraz S; Ertenli I; Oztürk MA; Haznedaroğlu IC; Celik I; Calgüneri M
    Thromb Res; 2002 Jan; 105(2):125-33. PubMed ID: 11958802
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protein C and protein S activities in Behçet's disease as risk factors of thrombosis.
    Lenk N; Ozet G; Alli N; Coban O; Erbaşi S
    Int J Dermatol; 1998 Feb; 37(2):124-5. PubMed ID: 9542668
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Subclinical pro-thrombotic state in a relapse of Behcet's disease--case report].
    Undas A; Pinis G
    Pol Arch Med Wewn; 1996 Sep; 96(3):258-62. PubMed ID: 9122017
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Factual or artificial inhibition of fibrinolysis and the occurrence of venous thrombosis in 3 cases of Behçet's disease.
    Kluft C; Michiels JJ; Wijngaards G
    Scand J Haematol; 1980 Nov; 25(5):423-30. PubMed ID: 6452679
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of hemostatic mechanisms in the development of thrombosis in Behcet's disease: an analysis by modified rotation thromboelastogram (ROTEM).
    Yaşar Bilge NŞ; Akay OM; Kaşifoğlu T; Kuş G; Korkmaz C
    Clin Rheumatol; 2013 Dec; 32(12):1815-8. PubMed ID: 23975360
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Could be serum uric acid a risk factor for thrombosis and/or uveitis in Behcet's disease?
    Atıl A; Deniz A
    Vascular; 2018 Aug; 26(4):378-386. PubMed ID: 29360007
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Do hemorheological alterations play any role in the development of thrombotic events in Behçet's disease?
    Vayá A; Ricart J; Todolí J; Micó L; Contreras T; Aznar J
    Clin Hemorheol Microcirc; 2004; 30(3-4):411-4. PubMed ID: 15258375
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hyperhomocysteinaemia in Behçet's disease.
    Aksu K; Turgan N; Oksel F; Keser G; Ozmen D; Kitapçioğlu G; Gümüşdiş G; Bayindir O; Doğanavşargil E
    Rheumatology (Oxford); 2001 Jun; 40(6):687-90. PubMed ID: 11426028
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Is Behçet's disease associated with characteristic abnormalities of coagulation and fibrinolysis? Apropos of 70 case reports].
    Conard J; Horellou MH; Wechsler B; Fassin D; Bletry O; Godeau P; Samama M
    J Mal Vasc; 1988; 13(3):257-61. PubMed ID: 3171405
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Platelet function, blood coagulation and fibrinolysis in Behcet's syndrome.
    Stathakis NE; Economopoulos TC; Papayannis AG; Thomopoulos D
    Blut; 1977 Mar; 34(3):215-22. PubMed ID: 843627
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vascular involvement in Behçet's disease: relation with thrombophilic factors, coagulation activation, and thrombomodulin.
    Espinosa G; Font J; Tàssies D; Vidaller A; Deulofeu R; López-Soto A; Cervera R; Ordinas A; Ingelmo M; Reverter JC
    Am J Med; 2002 Jan; 112(1):37-43. PubMed ID: 11812405
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Why are male patients with Behçet's disease prone to thrombosis? A rotational thromboelastographic analysis.
    Kara Kivanc B; Gönüllü E; Akay OM; Ertürk A; Bal C; Cansu DÜ; Korkmaz C
    Clin Exp Rheumatol; 2018; 36(6 Suppl 115):63-67. PubMed ID: 29998845
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Global fibrinolytic capacity in children on dialysis.
    Agras PI; Baskin E; Cengiz N; Kirazli S; Saatci U; Ozbek N
    Thromb Res; 2005; 115(3):185-9. PubMed ID: 15617740
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reduced erythrocyte deformability in active and untreated Behçet's disease patients.
    Tatlican S; Duran FS; Eren C; Eskioglu F; Dikmenoglu N; Oktay B; Durmazlar SP; Canpolat F
    Int J Dermatol; 2010 Feb; 49(2):167-71. PubMed ID: 20465640
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.